Discordance between body mass index and anthropometric measurements among HIV-1-infected patients on antiretroviral therapy and with lipoatrophy/lipohypertrophy syndrome.

Autor:	Soares LR; Dermatology Department, Secondary Immunodeficiencies Outpatient Clinic, São Paulo University Medical School, S. Paulo, SP, Brazil., da Silva DC; Dermatology Department, Secondary Immunodeficiencies Outpatient Clinic, São Paulo University Medical School, S. Paulo, SP, Brazil., Gonsalez CR; Dermatology Department, Secondary Immunodeficiencies Outpatient Clinic, São Paulo University Medical School, S. Paulo, SP, Brazil., Batista FG; Dermatology Department, Secondary Immunodeficiencies Outpatient Clinic, São Paulo University Medical School, S. Paulo, SP, Brazil., Fonseca LA; Preventive Medicine Department, São Paulo University Medical School, S. Paulo, SP, Brazil., Duarte AJ; Dermatology Department, Secondary Immunodeficiencies Outpatient Clinic, São Paulo University Medical School, S. Paulo, SP, Brazil., Casseb J; Dermatology Department, Secondary Immunodeficiencies Outpatient Clinic, São Paulo University Medical School, S. Paulo, SP, Brazil.
Jazyk:	angličtina
Zdroj:	Revista do Instituto de Medicina Tropical de Sao Paulo [Rev Inst Med Trop Sao Paulo] 2015 Mar-Apr; Vol. 57 (2), pp. 105-10.
DOI:	10.1590/S0036-46652015000200002
Abstrakt:	Introduction: Highly Active Antiretroviral Therapy (HAART) has improved and extended the lives of thousands of people living with HIV/AIDS around the world. However, this treatment can lead to the development of adverse reactions such as lipoatrophy/lipohypertrophy syndrome (LLS) and its associated risks. Objective: This study was designed to assess the prevalence of self-reported lipodystrophy and nutritional status by anthropometric measurements in patients with HIV/AIDS. Methods: An observational study of 227 adult patients in the Secondary Immunodeficiencies Outpatient Department of Dermatology, Hospital das Clínicas, Faculty of Medicine, University of São Paulo (3002 ADEE-HCFMUSP). The sample was divided into three groups; Group 1 = 92 patients on HAART and with self-reported lipodystrophy, Group 2 = 70 patients on HAART without self-reported lipodystrophy and Group 3 = 65 patients not taking HAART. The nutritional status of individuals in the study sample was determined by body mass index (BMI) and percentage of body fat (% BF). The cardiovascular risk and diseases associated with abdominal obesity were determined by waist/hip ratio (WHR) and waist circumference (WC). Results: The prevalence of self-reported lipoatrophy/lipohypertrophy syndrome was 33% among women and 59% among men. Anthropometry showed depletion of fat mass in the evaluation of the triceps (TSF) in the treatment groups with HAART and was statistically independent of gender; for men p = 0.001, and for women p = 0.007. Similar results were found in the measurement of skin folds of the upper and lower body (p = 0.001 and p = 0.003 respectively). In assessing the nutritional status of groups by BMI and % BF, excess weight and body fat were more prevalent among women compared to men (p = 0.726). The WHR and WC revealed risks for cardiovascular and other diseases associated with abdominal obesity for women on HAART and with self-reported LLS (p = 0.005) and (p = 0.011). Conclusions: Anthropometric measurements were useful in the confirmation of the prevalence of LLS. BMI alone does not appear to be a good parameter for assessing the nutritional status of HIV-infected patients on HAART and with LLS. Other anthropometric measurements are needed to evaluate patients with the lipoatrophy/lipohypertrophy syndrome.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu